Michael Cloutier

Mike Cloutier is an accomplished business leader and advisor with over 40 years in the Life Sciences sector. He is well respected for his leadership skills, business acumen, coaching and mentoring accomplishments. He remains active with a number of advisory roles. Over the past 25 years, Mike was General Manager, President and CEO of five major pharmaceutical firms and one Not for Profit organization, the Canadian Diabetes Association (now Diabetes Canada).

In 2017, Mike founded a Canadian based global consulting practice, Accelera Canada Ltd. Accelera Canada provides unique and unparalleled “one top support” to US and European based biotech/pharmaceutical companies exploring commercial entry to Canada. In July of 2021, Accelera was acquired by Eversana Life Sciences Services.

Over the past 4 years Mike has evolved a more entrepreneurial profile and engaged in the start-up of a number of Lifesciences related companies. Most recently, he co-founded two organizations. Noviscend to provide consultation, in-licensing and distribution to US/EU based medical device innovators.

BridgeBright to provide strategic staffing and leadership solutions. Prior to the role at Accelera Canada, Mike led organizations with interests in the Orphan and Rare disease market segments. As the General Manager and President of PTC Therapeutics Canada and InterMune Canada Inc., he ensured the delivery of tremendous support to patients and caregivers. These companies drove exceptional results in terms of optimal access for patients in need and financial success.

Mike has held positions in Latin America and Europe, serving as Senior Director, Operations, Latin America/Canada and as the Vice-President, Human Resources - Global Marketing for AstraZeneca Inc. 

Mike has been responsible for Life Cycle Management in a number of his senior leadership roles. In Canada, the US, Latin America and Europe both as a CEO and senior marketing leader of a number of companies. He has engaged in many significant therapeutic classes including Oncology, Neuro-muscular, Cardiology, Gastroenterology, Infectious Disease and Inflammation. Mike is active on a strategic level sitting and leading a variety of Boards. He sits on the Boards of Arylide, ODAIA, ProteoCyte and OBIO. As a result, Mike has an extensive network throughout Canada, the US and International circles.

Mike is a respected, dedicated philanthropist and has served on numerous Boards as a volunteer including the Canadian Stroke Network, Sheridan College Institute of Technology and Advanced Learning and the Canadian Orthopaedic Foundation. Mike is the past Fundraising Chair of the Hazel McCallion Academic Learning Centre at the University of Toronto Mississauga. Among his many accomplishments, Mike was inducted to the Sheridan College School of Business Marketing Hall of Fame and the Canadian Pharmaceutical Marketing Hall of Fame.

‍